About Endolastic
Revolutionizing Healthcare Through Innovative Ligation Technology
Our Story
Founded in 2024, Endolastic emerged from a vision to transform the landscape of minimally invasive treatments. Our co-founders recognized the potential of advanced ligation technology to address some of the most pressing challenges in gastroenterology and metabolic health.
Driven by a passion for innovation and a commitment to improving patient outcomes, Endolastic has rapidly evolved into a leading force in the development of groundbreaking endoscopic solutions.
Our Mission
At Endolastic, our mission is to revolutionize the treatment of chronic metabolic and gastrointestinal conditions through innovative, minimally invasive solutions. We strive to empower healthcare providers with cutting-edge technologies that enhance patient care, reduce procedural complexity, and improve quality of life.
Our Vision for the Future
As we look to the future, Endolastic remains committed to pushing the boundaries of endoscopic treatments. We envision a world where chronic metabolic and gastrointestinal conditions can be addressed through simple, effective, and minimally invasive procedures, dramatically improving patient outcomes and quality of life.
Our Approach
Endolastic's approach is rooted in three core principles:
Innovation
We continuously push the boundaries of what's possible in endoscopic treatments, leveraging our proprietary ligation technology to create novel solutions.
Simplicity
Our devices are designed to be intuitive and user-friendly, reducing the learning curve for healthcare providers and improving accessibility for patients.
Patient-Centricity
Every product and procedure we develop is guided by a commitment to enhancing patient outcomes and experiences.
Leadership Team
Fritz Haller
Co-founder & CEO
With over 20 years of experience in medical device innovation, Fritz leads Endolastic's strategic vision and operations.
Paul Robertson
Co-founder & CPO
Paul brings extensive expertise in biomedical engineering, driving Endolastic's technological advancements and R&D efforts.
Key Advisors
Dr. Mohamed Abeid
Consultant Gastroenterologist and Bariatric Endoscopist
Dr. Mohamed Abeid is a pioneering force in minimally invasive endoscopic treatments for obesity and GERD. With over 20 years of experience and more than 50,000 upper endoscopies performed, Dr. Abeid has been at the forefront of developing innovative techniques that align perfectly with Endolastic's mission.
Dr. Jose M. Nieto
Advanced Therapeutic Endoscopist
Dr. Jose M. Nieto is a visionary in advanced therapeutic endoscopy, whose work aligns seamlessly with Endolastic's innovative approach to gastrointestinal treatments. As the pioneer of the Antireflux Band Mucosectomy (ARBM) technique, Dr. Nieto has demonstrated the power of band ligation technology in treating refractory GERD.
Global Impact
Endolastic's solutions are making a difference in patients' lives across 15 countries. We're committed to expanding access to our innovative treatments globally, partnering with distributors and healthcare providers to bring minimally invasive options to those who need them most.